WorldQuant Millennium Advisors
CAI

WorldQuant Millennium Advisors’s Caris Life Sciences CAI Stock Holding History

WorldQuant Millennium Advisors’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.48M Buy
194,710
+5,849
+3% +$128K 0.01% 368
2025
Q4 		$5.1M Buy
188,861
+178,769
+1,771% +$5.03M 0.02% 330
2025
Q3 		$305K Buy
+10,092
New +$322K ﹤0.01% 477

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

WorldQuant Millennium Advisors's CAI Position: Q1 2026 in Review

WorldQuant Millennium Advisors increased its Caris Life Sciences (CAI) stake by 3.1% in Q1 2026, buying an estimated $128K and bringing the position to 194,710 shares worth $3.48M. The position accounts for 0.01% of the portfolio, ranked #368.

WorldQuant Millennium Advisors first reported a position in CAI in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.1M in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • WorldQuant Millennium Advisors held 194,710 shares of Caris Life Sciences worth $3.48M as of Q1 2026.
  • WorldQuant Millennium Advisors bought 5,849 Caris Life Sciences shares in Q1 2026, an estimated $128K.
  • Caris Life Sciences made up 0.01% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #368 holding.
  • WorldQuant Millennium Advisors first reported a position in Caris Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • WorldQuant Millennium Advisors's Caris Life Sciences position peaked at $5.1M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.